AT
BMRN icon

AMF Tjänstepension’s BioMarin Pharmaceuticals BMRN Stock Holding History

AMF Tjänstepension’s Portfolio BMRN Stock Details BMRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-24,714
Closed -$2.14M – 207
2023
Q2 		$2.14M Sell
24,714
-17,023
-41% -$1.6M 0.02% 211
2023
Q1 		$4.06M Hold
41,737
– – 0.04% 179
2022
Q4 		$4.32M Buy
+41,737
New +$3.92M 0.05% 179
2020
Q2 		– Sell
-97,032
Closed -$8.2M – 181
2020
Q1 		$8.2M Buy
+97,032
New +$8.36M 0.1% 149
2019
Q1 		– Sell
-176,236
Closed -$15M – 178
2018
Q4 		$15M Sell
176,236
-75,910
-30% -$7.22M 0.16% 157
2018
Q3 		$24.5M Sell
252,146
-3,610
-1% -$360K 0.22% 129
2018
Q2 		$24.1M Buy
255,756
+41,858
+20% +$3.67M 0.23% 137
2018
Q1 		$17.3M Sell
213,898
-13,771
-6% -$1.18M 0.18% 126
2017
Q4 		$20.3M Sell
227,669
-30,392
-12% -$2.64M 0.2% 126
2017
Q3 		$24M Sell
258,061
-1,771
-0.7% -$156K 0.26% 120
2017
Q2 		$22.8M Hold
259,832
– – 0.26% 129
2017
Q1 		$22.8M Sell
259,832
-10,319
-4% -$918K 0.26% 129
2016
Q4 		$22.4M Buy
+270,151
New +$23.2M 0.26% 130

Other funds holding BMRN

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

AMF Tjänstepension's BMRN Position: Q3 2023 in Review

AMF Tjänstepension sold out of BioMarin Pharmaceuticals (BMRN) in Q3 2023, closing a stake of 24,714 shares — an estimated $2.14M sold.

AMF Tjänstepension first reported a position in BMRN in Q4 2016 and held it in 13 quarters. The position peaked at $24.5M in Q3 2018. 519 funds tracked by Wall St. Rank hold BMRN as of Q3 2023.

  • AMF Tjänstepension reported no remaining BioMarin Pharmaceuticals position as of Q3 2023 after selling out during the quarter.
  • AMF Tjänstepension sold 24,714 BioMarin Pharmaceuticals shares in Q3 2023, an estimated $2.14M.
  • AMF Tjänstepension first reported a position in BioMarin Pharmaceuticals in Q4 2016 and held it in 13 quarters.
  • AMF Tjänstepension's BioMarin Pharmaceuticals position peaked at $24.5M in Q3 2018.
  • 519 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q3 2023.

Based on AMF Tjänstepension's 13F filing for Q3 2023, filed 26 Oct 2023.